Business Wire

The UK Chooses Bridge Over Troubled Water as the Nation’s Favourite Song of Hope in Solidarity With Refugees

19.1.2026 09:00:00 CET | Business Wire | Press Release

Share

Simon and Garfunkel’s Bridge Over Troubled Water has been votedas the UK’s number one #HopeHit ― as part of UK for UNHCR’s ‘Hope on Repeat’ campaign, raising awareness of the hardships facing refugees across the globe this winter.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260119165712/en/

Simon & Garfunkel's Bridge Over Troubled Water voted the UK's number one #HopeHit

With 10% of the public vote, Bridge Over Troubled Water emerged as the UK’s most popular #HopeHit. Since November, the UN Refugee Agency’s national charity partner has invited people to nominate their #HopeHits - the tunes that connect us and warm our hearts as the weather gets cold. The top hit is announced today, Blue Monday, to help people get through the most depressing day of the year.

The 1970 chart topper held off stiff competition from Stand By Me by Ben E King with 5.7% of the vote and Imagine by John Lennon with 5.3%.

Hope on Repeat in support of refugees

UK for UNHCR’s winter campaign ― Hope on Repeat ― aims to highlight the experiences of refugees around the world, with a specific focus on families from Afghanistan, Syria and Ukraine who will spend the winter forcibly displaced from their homes.

Music is widely seen as a universal language and a sign of solidarity. UK for UNHCR has worked with Royal College of Music academic, Norbert Meyn, to explore how music drives connection and empathy ― while a UK for UNHCR survey* shows that 73% of us believe that music unites people.

Hope on Repeat guest, Bosnian public speaker and researcher, Smajo OBE, said, “I was welcomed with open arms to the UK and Newcastle in 1994. At first, I felt out of place. But one song changed everything. My classmates and teacher sang it in Bosnian to make me feel at home.”

The Hope on Repeat campaign also features a series of five podcasts hosted by British poet, Sophia Thakur, that share the incredible stories of people forced to flee their homes ― named The Guardian’s podcast of the week. The Hope on Repeat podcast is available from www.unrefugees.org.uk/hope

Hope on Repeat guest, Ukrainian film director and producer, Mariia, said, “No matter the language, music has the power to make people feel something. It conveys the basic emotions of humanity.”

Visit unrefugees.org.uk/hope to find out what Mariia and Smajo's Hope Hits are and the stories behind them, and how you can support refugees this winter.

Editors Notes

For the latest statistics and reports, please visit UNHCR’s Operational Data Portal here. https://data.unhcr.org/

The video is available here: https://youtu.be/rTKO7zmChE0

Winning song graphic – here

Refugee Storyteller images – here

Hero video footage - YouTube / MP4

1148 people voted for their Hope Hit between 10 November 2025 and 13 January 2026.

About the survey

The UK for UNHCR-commissioned Censuswide survey questioned over 2,000 people from across England, Northern Ireland, Scotland and Wales in November 2025. Responses form a snapshot of UK attitudes to music’s role in building better cultural understanding and strengthening communities in 2025.

About UK for UNHCR

UK for UNHCR is the UN Refugee Agency’s national charity partner for the UK. We build solidarity, create partnerships and raise funds across the UK to help deliver global humanitarian relief for refugees through UNHCR’s work. unrefugees.org.uk

UNHCR, the UN Refugee Agency, leads international action to protect people forced to flee their homes because of conflict and persecution. It delivers lifesaving assistance like shelter, food and water, helps safeguard fundamental human rights and develops solutions that ensure people have a safe place to call home where they can build a better future. UNHCR also works to ensure that stateless people are granted a nationality. www.unhcr.org

UK for UNHCR is a registered charity in England and Wales (registered charity number 1183415).

View source version on businesswire.com: https://www.businesswire.com/news/home/20260119165712/en/

Contacts

For media enquiries, please contact:

Sanjiv Winayak | sanjiv@milkandhoneypr.com | +44 (0)777 336 270

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Emdoor Information Marks 18 Years of Rugged Computing Excellence with Vertically Integrated Capabilities10.10.2026 12:30:00 CEST | Press Release

As industrial automation, smart manufacturing, and field operations increasingly depend on mission-critical mobile computing, global demand for reliable rugged tablets, rugged laptops, and rugged handhelds continues to accelerate. Emdoor Information, a publicly listed company on China’s A-share main board since 2023 and an 18-year veteran in rugged computing, has established itself as a rugged computing solutions provider for industrial customers worldwide. Founded in 2008, the company delivers sustained growth, world-class manufacturing, resilient supply chains, full-stack R&D, and comprehensive lifecycle services. Its rugged computing products and industrial customers now span North America, Latin America, Europe, and Asia-Pacific, serving sectors such as public utilities, intelligent manufacturing, warehouse management, transportation, energy industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010564561/en/ Rugged

Vertex to Present New Data on ALYFTREK ® at the North American Cystic Fibrosis Conference9.10.2026 19:15:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine pancreatic function represent a profound shift in how we understand the benefits of treating cystic fibrosis in its earliest stages,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Devel

Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment9.10.2026 16:00:00 CEST | Press Release

Verdant Rock Limited, a Bermuda Monetary Authority-regulated Class 3B insurance company, has received an A (low) Financial Strength Rating from Morningstar DBRS. The rating reflects Verdant Rock’s financial strength and its capacity to meet policyholder obligations as an investment-grade financial guarantor for Emerging Markets credit. Morningstar DBRS is a global credit rating agency with coverage across North America, Europe, Asia, and Latin America. Its assessment of Verdant Rock reflects the company’s strong projected earnings ability, robust risk profile, sound liquidity, and good capitalization. Morningstar DBRS also assigned an A (low) Issuer Rating to Verdant Rock. The rating follows Verdant Rock’s BBB+ Long-Term Insurer Financial Strength Rating with a Stable Outlook from Fitch Ratings, assigned on 12 June 2026. Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation of the company’s

Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions9.10.2026 15:17:00 CEST | Press Release

Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced that Gartner has positioned it as a Visionary in the first-ever Magic Quadrant for AI-Enabled CSP Marketing and Sales Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009905430/en/ Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions A new category for a new operating model. CSPs are fighting saturated markets, rising acquisition costs, and accelerating churn. They are responding with AI-driven automation across the full revenue cycle, from segmentation and campaigns to lead management, CPQ, and renewals, increasingly executed by autonomous agents. According to us, Gartner creation of this Magic Quadrant confirms the shift has moved from pilot to boardroom priority. According to Gartner, Visionaries "understands where the market

Positive New Data on Corcym’s Perceval Plus Sutureless Aortic Heart Valve Encompasses up to 7-Year Follow-up9.10.2026 15:15:00 CEST | Press Release

Corcym, a global medical device company dedicated to cardiac surgery, today announced that positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve as part of its MANTRA clinical trial was featured in an oral presentation today at the annual meeting of the European Association for Cardio-Thoracic Surgery (EACTS). The study is the longest follow-up available for Perceval Plus and the FREE tissue treatment from an international multicenter study, and demonstrated excellent durability, safety and quality of life improvements. Perceval Plus is the only sutureless and collapsible aortic surgical heart valve. Its unique design performs in any surgical scenario and is optimal for endoscopy and robotics. The valve features the company’s FREE next generation tissue treatment addressing the two main causes of calcification, phospholipids and aldehydes. Its proprietary LANCELOT advanced manufacturing process includes zero-pressure shaping and laser cutting of

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye